Evaluation of MGMT Promoter Methylation Status and Correlation with Temozolomide Response in Orthotopic Glioblastoma Xenograft Model

CpG methylation within the O6-methylguanine-DNA-methyltransferase (MGMT) promoter is associated with enhanced survival of glioblastoma multiforme (GBM) patients treated with temozolomide (TMZ). Although MGMT promoter is methylated in ~50% of GBM, several studies have reported a lack of correlation b...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kitange, Gaspar J., Carlson, Brett L., Mladek, Ann C., Decker, Paul A., Schroeder, Mark A., Wu, Wenting, Grogan, Patrick T., Giannini, Caterina, Ballman, Karla V., Buckner, Jan C., James, C. David, Sarkaria, Jann N.
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2790867/
https://ncbi.nlm.nih.gov/pubmed/19011762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-008-9737-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires